Autoimmune Mechanisms in ALS Reveal New Disease Insights
Originally Published 3 months ago — by Nature

The study identifies C9orf72 as a major autoantigen targeted by CD4+ T cells in ALS patients, with responses skewed towards an anti-inflammatory profile, especially in those with longer survival, suggesting a potential protective immune component in ALS progression.
